Cell fusion in osteoclasts plays a critical role in controlling bone mass and osteoblastic activity
Ryotaro Iwasaki(Keio University), Takeshi Miyamoto(Kumamoto Health Science University), Taneaki Nakagawa(Keio University), Hiromasa Kawana, Toshio Suda(Chinese Academy of Sciences), Ken Ninomiya(Kawasaki Hospital), T. Suzuki, Yuiko Sato(Keio University), Kana Miyamoto(Kumamoto University)
Cited by 57
Related Papers
Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
|Proceedings of the National Academy of Sciences|1998|4.3k
Identity of Osteoclastogenesis Inhibitory Factor (OCIF) and Osteoprotegerin (OPG): A Mechanism by which OPG/OCIF Inhibits Osteoclastogenesis<i>in Vitro</i><sup>1</sup>
|Endocrinology|1998|1.2k
DC-STAMP is essential for cell–cell fusion in osteoclasts and foreign body giant cells
|The Journal of Experimental Medicine|2005|899
Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis
|Cell Metabolism|2006|771
Commitment and Differentiation of Osteoclast Precursor Cells by the Sequential Expression of C-Fms and Receptor Activator of Nuclear Factor κb (Rank) Receptors
|The Journal of Experimental Medicine|1999|694